| |
| |
|
| Insider
Information: |
Pauli Ronald |
| Relationship: |
Director |
| City: |
Los Angeles |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
3,680 |
|
|
Indirect Shares
|
33,600 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$950,880 |
|
|
| Total
Shares |
37,280 |
|
|
| Total
Value |
$950,880 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sagent Pharmaceuticals Inc |
SGNT |
Chief Financial Officer |
2012-02-22 |
3,680 |
2012-02-22 |
0 |
Premium* |
|
|
Horizon Pharma, Inc. |
HZNP |
Director |
2016-05-06 |
0 |
2019-05-02 |
33,600 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
9 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2019-05-02 |
4 |
D |
$25.99 |
$156,304 |
I/I |
(6,014) |
33,600 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2019-05-02 |
4 |
OE |
$0.00 |
$0 |
I/I |
15,320 |
39,614 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2018-05-03 |
4 |
D |
$13.87 |
$52,567 |
I/I |
(3,790) |
24,294 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2018-05-03 |
4 |
OE |
$0.00 |
$0 |
I/I |
14,054 |
28,084 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2017-05-03 |
4 |
D |
$15.12 |
$56,897 |
I/I |
(3,763) |
14,030 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2017-05-03 |
4 |
OE |
$0.00 |
$0 |
I/I |
13,953 |
17,793 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2016-05-06 |
4 |
D |
$13.41 |
$19,015 |
I/I |
(1,418) |
3,840 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2016-05-06 |
4 |
OE |
$0.00 |
$0 |
I/I |
5,258 |
5,258 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2012-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
3,680 |
3,680 |
0 |
- |
|
9 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
